Previous studies have suggested that SNX16 exhibited alternative splicing in certain melanoma cell lines and could interact with 32 SNPs, which is a known risk factor for prostate cancer (Tao et al., 2012; Watahiki et al., 2004). This evidence concerns the gene SNX16 and prostate cancer.